Skip to main content
2024 ACRO Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Evaluation

Physician

SEAL

2024 Coding & Reimbursement Update

Wednesday, March 13, 2024
2:00 PM - 5:00 PM ET
Location: Narcissus/Orange
CME 3 Credits

    Speaker(s)

  • Ronald DiGiaimo, MBA, FACHE (he/him/his)

    CEO
    Revenue Cycle Coding Strategies
    Cedar Park, Texas, United States

    Disclosure(s): RC Billing: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Regents Healthcare: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Revenue Cycle Coding Strategies: Consultant (Ongoing), Employment (full or part time) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Teri Bedard, BA, RT(R)(T), CPC

    Executive Director, Client & Corporate Resources
    Revenue Cycle Coding Strategies
    Cedar Park, TX, United States

    Disclosure information not submitted.

Disclosure(s):
Ronald DiGiaimo, MBA, FACHE: RC Billing: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Regents Healthcare: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Revenue Cycle Coding Strategies: Consultant (Ongoing), Employment (full or part time) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)